> Details

Dreher, Matthias; Witte, Torsten; Hoeper, Kirsten; Assmann, Gunter; Proft, Fabian; Poddubnyy, Denis; Murawski, Niels; Triantafyllias, Konstantinos; Grodd, Marlon; Graf, Erika; Fichtner, Urs A; Binder, Harald; Zeidler, Jan; Hoeper, Juliana Rachel; Callhoff, Johanna; Karberg, Kirsten; Trautwein, Anna; Tibyampansha, Dativa; Wojnowski, Leszek; Schmidt, Reinhold E; Schwarting, Andreas

Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres
  • Contributor: Dreher, Matthias; Witte, Torsten; Hoeper, Kirsten; Assmann, Gunter; Proft, Fabian; Poddubnyy, Denis; Murawski, Niels; Triantafyllias, Konstantinos; Grodd, Marlon; Graf, Erika; Fichtner, Urs A; Binder, Harald; Zeidler, Jan; Hoeper, Juliana Rachel; Callhoff, Johanna; Karberg, Kirsten; Trautwein, Anna; Tibyampansha, Dativa; Wojnowski, Leszek; Schmidt, Reinhold E; Schwarting, Andreas
  • Published: BMJ, 2024
  • Published in: Annals of the Rheumatic Diseases, 83 (2024) 2, Seite 184-193
  • Language: English
  • DOI: 10.1136/ard-2023-224205
  • ISSN: 0003-4967; 1468-2060
  • Origination:
  • Footnote:
  • Description: ObjectivesEarly diagnosis of inflammatory arthritis is critical to prevent joint damage and functional incapacities. However, the discrepancy between recommendations of early diagnosis and reality is remarkable. The Rheuma-VOR study aimed to improve the time to diagnosis of patients with early arthritis by coordinating cooperation between primary care physicians, specialists and patients in Germany.MethodsThis prospective non-randomised multicentre study involved 2340 primary care physicians, 72 rheumatologists, 4 university hospitals and 4 rheumatology centres in 4 German Federal States. The two coprimary endpoints (time to diagnosis and screening performance of primary care physicians) were evaluated for early versus late implementation phase. Additionally, time to diagnosis and secondary endpoints (decrease of disease activity, increase in quality of life and overall well-being, improvement of fatigue, depression, functional ability, and work ability, reduction in drug and medical costs and hospitalisation) were compared with a reference cohort of the German Rheumatism Research Centre (DRFZ) reflecting standard care.ResultsA total of 7049 patients were enrolled in the coordination centres and 1537 patients were diagnosed with a rheumatic disease and consented to further participation. A follow-up consultation after 1 year was realised in 592 patients. The time to diagnosis endpoint and the secondary endpoints were met. In addition, the calculation of cost-effectiveness shows that Rheuma-VOR has a dominant cost–benefit ratio compared with standard care.DiscussionRheuma-VOR has shown an improvement in rheumatological care, patient-reported outcome parameters and cost savings by coordinating the cooperation of primary care physicians, rheumatologists and patients, in a nationwide approach.